Skip to content
10-Q

Quarterly Report

Astria Therapeutics, Inc.

0001104659-25-110377

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 57.08M sh
Shares Diluted Q3 2025 · Sep 30, 2025 58.01M sh
Shares Diluted Q3 2025 · Sep 30, 2025 58.01M sh
Shares Diluted Q3 2025 · Sep 30, 2024 57.82M sh
Shares Diluted Q3 2025 · Sep 30, 2024 55.54M sh
Capex Q3 2025 · Sep 30, 2025 $590K
Capex Q3 2025 · Sep 30, 2024 $325K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$102.37M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$63.85M
Short Term Investments Q3 2025 · Sep 30, 2025 $131.44M
Short Term Investments Q3 2025 · Dec 31, 2024 $268.31M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $96.28M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $59.82M
Stockholders Equity Q3 2025 · Sep 30, 2025 $233.25M
Stockholders Equity Q3 2025 · Jun 30, 2025 $260.51M
Stockholders Equity Q3 2025 · Mar 31, 2025 $289.29M
Stockholders Equity Q3 2025 · Dec 31, 2024 $319.26M
Stockholders Equity Q3 2025 · Sep 30, 2024 $341.65M
Stockholders Equity Q3 2025 · Jun 30, 2024 $347.08M
Stockholders Equity Q3 2025 · Mar 31, 2024 $367.74M
Stockholders Equity Q3 2025 · Dec 31, 2023 $243.12M
Current Liabilities Q3 2025 · Sep 30, 2025 $23.52M
Current Liabilities Q3 2025 · Dec 31, 2024 $19.13M
Total Liabilities Q3 2025 · Sep 30, 2025 $38.61M
Total Liabilities Q3 2025 · Dec 31, 2024 $23.1M
Current Assets Q3 2025 · Sep 30, 2025 $253.55M
Current Assets Q3 2025 · Dec 31, 2024 $334.64M
Total Assets Q3 2025 · Sep 30, 2025 $271.87M
Total Assets Q3 2025 · Dec 31, 2024 $342.36M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.55
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.70
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.42
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.24
Eps Basic Q3 2025 · Sep 30, 2025 −$0.55
Eps Basic Q3 2025 · Sep 30, 2025 −$1.70
Eps Basic Q3 2025 · Sep 30, 2024 −$0.42
Eps Basic Q3 2025 · Sep 30, 2024 −$1.24
Sga Expense Q3 2025 · Sep 30, 2025 $10.66M
Sga Expense Q3 2025 · Sep 30, 2025 $29.75M
Sga Expense Q3 2025 · Sep 30, 2024 $8.5M
Sga Expense Q3 2025 · Sep 30, 2024 $25.02M
Net Income Q3 2025 · Sep 30, 2025 −$31.64M
Net Income Q3 2025 · Sep 30, 2025 −$98.4M
Net Income Q3 2025 · Jun 30, 2025 −$33.05M
Net Income Q3 2025 · Mar 31, 2025 −$33.71M
Net Income Q3 2025 · Sep 30, 2024 −$24.53M
Net Income Q3 2025 · Sep 30, 2024 −$68.63M
Net Income Q3 2025 · Jun 30, 2024 −$24.17M
Net Income Q3 2025 · Mar 31, 2024 −$19.93M
Operating Income Q3 2025 · Sep 30, 2025 −$34.1M
Operating Income Q3 2025 · Sep 30, 2025 −$106.92M
Operating Income Q3 2025 · Sep 30, 2024 −$29.01M
Operating Income Q3 2025 · Sep 30, 2024 −$81.97M
Revenue Q3 2025 · Sep 30, 2025 $706K
Revenue Q3 2025 · Sep 30, 2025 $706K
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $0